This suggests that BCL10 may inhibit the infiltration of CD8+T cells, CD4+Th1 cells, and NKT cells in the TIME by increasing the expression of LAG3 and PDCD1, thereby promoting the progression of CESC. Here, BCL10 is linked to cervical squamous cell carcinoma.